These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18173904)

  • 41. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of rapid brain imaging in acute stroke: analysis of the Get With the Guidelines-Stroke program.
    Kelly AG; Hellkamp AS; Olson D; Smith EE; Schwamm LH
    Stroke; 2012 May; 43(5):1279-84. PubMed ID: 22442169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group.
    Brophy JM; Diodati JG; Bogaty P; Théroux P
    CMAJ; 1998 Feb; 158(4):475-80. PubMed ID: 9627559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poor recognition of prompted treatment seeking even with good knowledge of stroke warning signs contribute to delayed arrival of acute ischemic stroke patients in Thailand.
    Muengtaweepongsa S; Hunghok W; Harnirattisai T
    J Stroke Cerebrovasc Dis; 2014; 23(5):948-52. PubMed ID: 24139409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
    ;
    Ann Emerg Med; 2013 Feb; 61(2):225-43. PubMed ID: 23331647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.
    Rost NS; Smith EE; Pervez MA; Mello P; Dreyer P; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):314-20. PubMed ID: 22534407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004.
    Lichtman JH; Watanabe E; Allen NB; Jones SB; Dostal J; Goldstein LB
    Stroke; 2009 Dec; 40(12):3845-50. PubMed ID: 19797697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
    Johnson M; Bakas T
    J Neurosci Nurs; 2010 Apr; 42(2):88-94. PubMed ID: 20422794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
    Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    de la Ossa NP; Sánchez-Ojanguren J; Palomeras E; Millán M; Arenillas JF; Dorado L; Guerrero C; Abilleira S; Dávalos A
    Neurology; 2008 Apr; 70(15):1238-43. PubMed ID: 18322264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke.
    Messé SR; Fonarow GC; Smith EE; Kaltenbach L; Olson DM; Kasner SE; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):321-6. PubMed ID: 22550132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stroke thrombolysis: having more time translates into delayed therapy: data from the Austrian Stroke Unit Registry.
    Ferrari J; Knoflach M; Kiechl S; Willeit J; Matosevic B; Seyfang L; Lang W;
    Stroke; 2010 Sep; 41(9):2001-4. PubMed ID: 20689080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.